متابعة
Antonio D'Avolio
Antonio D'Avolio
University of Turin, Medical Sciences Dpt., Lab. Clinical Pharmacology and Pharmacogenetics
بريد إلكتروني تم التحقق منه على unito.it
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2
A D’Avolio, V Avataneo, A Manca, J Cusato, A De Nicolò, R Lucchini, ...
Nutrients 12 (5), 1359, 2020
5442020
In vitro activity of propolis againstStreptococcus pyogenes
K Bosio, C Avanzini, A D'avolio, O Ozino, D Savoia
Letters in applied microbiology 31 (2), 174-177, 2000
2952000
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations
S Rodríguez-Nóvoa, P Labarga, A D'avolio, P Barreiro, M Albalate, ...
Aids 24 (7), 1064-1066, 2010
1632010
Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients
S Cosma, AR Carosso, J Cusato, F Borella, M Carosso, M Bovetti, ...
American journal of obstetrics and gynecology 224 (4), 391. e1-391. e7, 2021
1602021
HPLC–MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients
A D’Avolio, M Siccardi, M Sciandra, B Lorena, S Bonora, L Trentini, ...
Journal of Chromatography B 859 (2), 234-240, 2007
1432007
A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir …
A Ariaudo, F Favata, A De Nicolò, M Simiele, L Paglietti, L Boglione, ...
Journal of pharmaceutical and biomedical analysis 125, 369-375, 2016
1332016
New HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma
S De Francia, A D’Avolio, F De Martino, E Pirro, L Baietto, M Siccardi, ...
Journal of Chromatography B 877 (18-19), 1721-1726, 2009
1332009
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 …
A D'Avolio, L Baietto, M Siccardi, M Sciandra, M Simiele, V Oddone, ...
Therapeutic Drug Monitoring 30 (6), 662-669, 2008
1322008
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19
M Tempestilli, P Caputi, V Avataneo, S Notari, O Forini, L Scorzolini, ...
Journal of Antimicrobial Chemotherapy 75 (10), 2977-2980, 2020
1072020
HPLC–MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions
A D’Avolio, M Simiele, M Siccardi, L Baietto, M Sciandra, S Bonora, ...
Journal of pharmaceutical and biomedical analysis 52 (5), 774-780, 2010
1062010
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study
A Berruti, N Fazio, A Ferrero, MP Brizzi, M Volante, E Nobili, L Tozzi, ...
BMC cancer 14, 1-10, 2014
952014
Association of a Single-Nucleotide Polymorphism in the Pregnane X Receptor (PXR 63396C→T) with Reduced Concentrations of Unboosted Atazanavir
M Siccardi, A D'Avolio, L Baietto, S Gibbons, M Sciandra, D Colucci, ...
Clinical infectious diseases 47 (9), 1222-1225, 2008
932008
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma
L Baietto, A D’Avolio, FG De Rosa, S Garazzino, M Michelazzo, ...
Analytical and bioanalytical chemistry 396, 791-798, 2010
922010
A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?
L Baietto, S Corcione, G Pacini, G Di Perri, A D’Avolio, ...
Current Drug Metabolism 15 (6), 581-598, 2014
912014
Population pharmacokinetic modeling of the association between 63396C→ T pregnane X receptor polymorphism and unboosted atazanavir clearance
A Schipani, M Siccardi, A D'Avolio, L Baietto, M Simiele, S Bonora, ...
Antimicrobial agents and chemotherapy 54 (12), 5242-5250, 2010
902010
HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)
A D’Avolio, M Simiele, S De Francia, A Ariaudo, L Baietto, J Cusato, ...
Journal of pharmaceutical and biomedical analysis 59, 109-116, 2012
852012
Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy
A Yilmaz, C Verhofstede, A D'Avolio, V Watson, L Hagberg, D Fuchs, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (5), 590-596, 2010
852010
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2 …
V Avataneo, A de Nicolò, J Cusato, M Antonucci, A Manca, A Palermiti, ...
Journal of Antimicrobial Chemotherapy 75 (7), 1772-1777, 2020
842020
LC-MS application for therapeutic drug monitoring in alternative matrices
V Avataneo, A D’Avolio, J Cusato, M Cantù, A De Nicolò
Journal of pharmaceutical and biomedical analysis 166, 40-51, 2019
842019
Atazanavir Ctrough is associated with efficacy and safety: definition of therapeutic range
D Gonzalez de Requena, S Bonora, F Canta, R Marrone, A D’Avolio, ...
Age (years) 170, 165-174, 2005
802005
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20